Lab
Laboratorio Clinico Fajardo, INC.
Laboratorio Clinico Fajardo, INC. was paid $691K by Medicaid between Jan 2018 and Oct 2024, across 42 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 28% of everything it billed.
33Billing provider infoLABORATORIO CLINICO FAJARDO, INC.
FAJARDO, PR 00738
FAJARDO, PR 00738
33aNPI1740247253assigned 04/27/2006
33bProvider typeClinical Medical Laboratory
28Total paid$691K
24GClaims47,433
24DCodes billed42
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#184 of 777
Median peer was paid$278K
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,510 | $11K | |
| 2019 | 684 | $4K | |
| 2020 | 3,106 | $24K | |
| 2021 | 12,419 | $232K | |
| 2022 | 10,823 | $186K | |
| 2023 | 9,785 | $117K | |
| 2024incomplete | 9,106 | $116K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 28% | 5,671 | 5,014 | $193K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19% | 5,629 | 4,907 | $132K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.3% | 3,477 | 3,200 | $50K |
| 80061 | Lipid panel | 6.0% | 3,397 | 3,146 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 5,609 | 5,029 | $37K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.5% | 2,572 | 1,181 | $31K |
| 80053 | Comprehensive metabolic panel | 4.5% | 3,355 | 3,053 | $31K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.0% | 586 | 537 | $28K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.0% | 763 | 691 | $21K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.4% | 1,810 | 1,669 | $16K |
| 81000 | 2.0% | 4,515 | 4,132 | $14K | |
| 86738 | 1.9% | 1,156 | 1,056 | $13K |
30 more codes
| 86328 | 1.7% | 652 | $12K | |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 984 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 874 | $7K |
| 82274 | <1% | 417 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 173 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 172 | $6K |
| 85027 | <1% | 1,063 | $6K | |
| 87276 | <1% | 264 | $4K | |
| 82043 | <1% | 687 | $4K | |
| 84436 | <1% | 521 | $3K | |
| 84479 | <1% | 552 | $3K | |
| 87275 | <1% | 265 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 108 | $3K |
| 87088 | <1% | 339 | $3K | |
| 86701 | <1% | 299 | $2K | |
| 84439 | <1% | 255 | $2K | |
| 86592 | <1% | 486 | $2K | |
| 84153 | <1% | 83 | $1K | |
| 82570 | <1% | 229 | $1K | |
| 80050 | General health panel | <1% | 69 | $640.69 |
| 87590 | <1% | 31 | $493.20 | |
| 82607 | <1% | 32 | $480.93 | |
| 87490 | <1% | 31 | $460.54 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 55 | $436.60 |
| 82950 | <1% | 42 | $189.05 | |
| 83655 | <1% | 16 | $129.43 | |
| 87177 | <1% | 12 | $124.60 | |
| 82042 | <1% | 15 | $107.00 | |
| 85651 | <1% | 27 | $67.87 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 140 | $1.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAVILES, WANDA (OWNER-PRESIDENT OF CORP-LAB. SUPERV)